ProbaLabs is making waves in the biotech industry with the development of its new prototype, OrganoInsight®. Unlike traditional methods that require destroying cells for analysis (end-point analysis), OrganoInsight® uses a multimodal biosensor system to monitor the health of organoids in real-time without causing any damage.
By applying semiconductor inspection logic to biological models, this technology allows researchers to observe electrical, chemical, and optical data simultaneously. This breakthrough is expected to significantly accelerate drug discovery and clinical trials by providing more accurate, live-cell data.
🔗 Check out the full story here: Money Today Article